SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3D - Registration of securities, dividend or interest reinvestment plans, immediately effective:
SEC Accession No. 0000950123-10-102757
Filing Date
2010-11-09
Accepted
2010-11-08 21:40:56
Documents
13
Effectiveness Date
2010-11-09

Document Format Files

Seq Description Document Type Size
1 FORM S-3D a57750sv3d.htm S-3D 224363
2 EX-4.5 a57750exv4w5.htm EX-4.5 12223
3 EX-4.6 a57750exv4w6.htm EX-4.6 89359
4 EX-5.1 a57750exv5w1.htm EX-5.1 9417
5 EX-8.2 a57750exv8w2.htm EX-8.2 7009
6 EX-23.3 a57750exv23w3.htm EX-23.3 2527
7 GRAPHIC a57750a5775000.gif GRAPHIC 2566
8 GRAPHIC a57750a5775001.gif GRAPHIC 2563
9 GRAPHIC a57750a5775002.gif GRAPHIC 17922
10 GRAPHIC a57750a5775004.gif GRAPHIC 4130
11 GRAPHIC a57750a5775005.gif GRAPHIC 9720
12 GRAPHIC a57750a5775006.gif GRAPHIC 3615
13 GRAPHIC a57750a5775003.gif GRAPHIC 51346
  Complete submission text file 0000950123-10-102757.txt   474171
Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000
Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: S-3D | Act: 33 | File No.: 333-170478 | Film No.: 101174123
SIC: 2834 Pharmaceutical Preparations